Literature DB >> 32947614

Parkinson's disease progression in the substantia nigra: location, location, location.

David E Vaillancourt1,2,3, Trina Mitchell2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32947614      PMCID: PMC7823227          DOI: 10.1093/brain/awaa252

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


× No keyword cloud information.
  13 in total

1.  Disease duration and the integrity of the nigrostriatal system in Parkinson's disease.

Authors:  Jeffrey H Kordower; C Warren Olanow; Hemraj B Dodiya; Yaping Chu; Thomas G Beach; Charles H Adler; Glenda M Halliday; Raymond T Bartus
Journal:  Brain       Date:  2013-08       Impact factor: 13.501

2.  Free water elimination and mapping from diffusion MRI.

Authors:  Ofer Pasternak; Nir Sochen; Yaniv Gur; Nathan Intrator; Yaniv Assaf
Journal:  Magn Reson Med       Date:  2009-09       Impact factor: 4.668

3.  Longitudinal changes in free-water within the substantia nigra of Parkinson's disease.

Authors:  Edward Ofori; Ofer Pasternak; Peggy J Planetta; Hong Li; Roxana G Burciu; Amy F Snyder; Song Lai; Michael S Okun; David E Vaillancourt
Journal:  Brain       Date:  2015-05-16       Impact factor: 13.501

4.  Increased free water in the substantia nigra of Parkinson's disease: a single-site and multi-site study.

Authors:  Edward Ofori; Ofer Pasternak; Peggy J Planetta; Roxana Burciu; Amy Snyder; Marcelo Febo; Todd E Golde; Michael S Okun; David E Vaillancourt
Journal:  Neurobiol Aging       Date:  2014-10-31       Impact factor: 4.673

5.  Age-specific progression of nigrostriatal dysfunction in Parkinson's disease.

Authors:  Raúl de la Fuente-Fernández; Michael Schulzer; Lisa Kuramoto; Jacquelyn Cragg; Nandhagopal Ramachandiran; Wing L Au; Edwin Mak; Jess McKenzie; Siobhan McCormick; Vesna Sossi; Thomas J Ruth; Chong S Lee; Donald B Calne; A Jon Stoessl
Journal:  Ann Neurol       Date:  2011-01-18       Impact factor: 10.422

6.  Ageing and Parkinson's disease: substantia nigra regional selectivity.

Authors:  J M Fearnley; A J Lees
Journal:  Brain       Date:  1991-10       Impact factor: 13.501

7.  High-resolution diffusion tensor imaging in the substantia nigra of de novo Parkinson disease.

Authors:  D E Vaillancourt; M B Spraker; J Prodoehl; I Abraham; D M Corcos; X J Zhou; C L Comella; D M Little
Journal:  Neurology       Date:  2009-01-07       Impact factor: 9.910

8.  Free-water imaging in Parkinson's disease and atypical parkinsonism.

Authors:  Peggy J Planetta; Edward Ofori; Ofer Pasternak; Roxana G Burciu; Priyank Shukla; Jesse C DeSimone; Michael S Okun; Nikolaus R McFarland; David E Vaillancourt
Journal:  Brain       Date:  2015-12-24       Impact factor: 13.501

9.  Life span pigmentation changes of the substantia nigra detected by neuromelanin-sensitive MRI.

Authors:  Yue Xing; Abdul Sapuan; Rob A Dineen; Dorothee P Auer
Journal:  Mov Disord       Date:  2018-11-13       Impact factor: 10.338

10.  Progression marker of Parkinson's disease: a 4-year multi-site imaging study.

Authors:  Roxana G Burciu; Edward Ofori; Derek B Archer; Samuel S Wu; Ofer Pasternak; Nikolaus R McFarland; Michael S Okun; David E Vaillancourt
Journal:  Brain       Date:  2017-08-01       Impact factor: 13.501

View more
  1 in total

Review 1.  Gene Therapeutic Approaches for the Treatment of Mitochondrial Dysfunction in Parkinson's Disease.

Authors:  Jannik Prasuhn; Norbert Brüggemann
Journal:  Genes (Basel)       Date:  2021-11-22       Impact factor: 4.096

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.